Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019064234) TREATMENT OF FRAGILE X SYNDROME WITH CANNABIDIOL
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2019/064234 International Application No.: PCT/IB2018/057519
Publication Date: 04.04.2019 International Filing Date: 27.09.2018
IPC:
A61K 31/05 (2006.01) ,A61P 25/00 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
045
Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
05
Phenols
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25
Drugs for disorders of the nervous system
Applicants:
ZYNERBA PHARMACEUTICALS, INC. [US/US]; 80 W. Lancaster Avenue Suite 300 Devon, PA 19333, US
Inventors:
BONN-MILLER, Marcel; US
TICH, Nancy; US
GUTTERMAN, Donna; US
MESSENHEIMER, John; US
SEBREE, Terri; US
Agent:
BARNES, Rebecca N.; US
Priority Data:
62/564,83428.09.2017US
62/632,53220.02.2018US
Title (EN) TREATMENT OF FRAGILE X SYNDROME WITH CANNABIDIOL
(FR) TRAITEMENT DU SYNDROME DE L'X FRAGILE AVEC DU CANNABIDIOL
Abstract:
(EN) The present technology relates to a method of treating one or more behavioral symptoms of Fragile X Syndrome in a subject by transdermally administering an effective amount of cannabidiol (CBD) to the subject wherein one or more behavioral symptoms of Fragile X Syndrome are treated in the subject.
(FR) La présente technologie concerne un procédé de traitement d'un ou plusieurs symptômes comportementaux du syndrome de l'X fragile chez un sujet, consistant à administrater par voie transdermique une quantité efficace de cannabidiol (CBD) au sujet, un ou plusieurs symptômes comportementaux du syndrome de l'X fragile étant traités chez ce sujet.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)